Acorda Therapeutics Inc. (NASDAQ: ACOR) shares are -74.41% down in the year-to-date (YTD) period and have moved -6.78% or -$0.04 lower in the latest trading session. However, stock’s trailing 12-month performance remains nearly +3.57% lower. Comparatively, the stock is -81.15% down YTD and -33.91% over the trailing 3-month period. If we look at the shorter duration, its week performance is -14.17% and -29.92% over the month.
On May 23, 2019, Wedbush recommended the ACOR stock is a Neutral, while earlier, H.C. Wainwright had Downgrade the stock as a Neutral on August 14, 2019. 5 analysts offering the recommendations for the stock have a consensus rating of 3.00 to suggest that the ACOR stock is a “Hold. 1 of the 5 analysts rate the stock as a “Sell”, while 0 has rated it as “Underweight”. 1 recommend buying, with 0 rating it as an Overweight.
The stock currently trades at $0.52. The forecasts give the Acorda Therapeutics Inc. stock a price target range of $5.00 on the higher side while at least one analyst think the stock could plunge to a low of $1.00. The two limits represent an upside potential of 89.6% or 48.0%.
Analysts estimate the earnings to increase 27.10% in the current quarter to -$0.31, up from the -$0.46 reported in the same quarter a year ago. For the current year, earnings should grow to an average of -$1.64, down -38.00% from -$1.72 reported last year. Analysts also offered guidance for the next financial quarter, with their average projected EPS at between -$0.51 and -$0.36. Wall Street estimates earnings per share to be at an average of -$1.84 for the next year.
Insider Transactions Summary
According to SEC data, total insider shares purchases at the company stands at 0 over the last 12 months, while SEC filings reveal that there have been 4 insider sales over the same period. Insiders have purchases 0 shares while those sold by company executives and officers stand at 9,615. The last 3 months have seen insiders trade a total of 0 and 0 in purchases and sales respectively.
Sabella Lauren M, a Chief Commercial Officer at the company, sold 1,513 shares worth $2421.0 at $1.60 per share on Dec 02. The President, Intl and GC had earlier sold another 2,227 ACOR shares valued at $3553.0 on Dec 02. The shares were sold at $1.60 per share. LAWRENCE DAVID (Chief, Bus. Ops & PAO) sold 1,176 shares at $1.60 per share on Dec 02 for a total of $1880.0 while COHEN RON, (President and CEO) sold 4,699 shares on Dec 02 for $7505.0 with each share fetching $1.60.
Caesars Entertainment Inc. (NASDAQ:CZR), on the other hand, is trading around $43.86 with a market cap of $7.26B and analyst research firms have a negative stance on its shares. Analysts predict that the stock will reach $11.96 and spell out a less modest performance – a -266.72% return. Some analysts are even forecasting -$2 per share in earnings this year on a short term (1 year) basis.
Let us briefly look at the Caesars Entertainment Inc. (CZR) financials, with a focus on its operating details as indicated in its earnings report for the last quarter.
Company balance sheet and cash flow
CZR’s operating margin was positive on the trailing 12 months basis, remaining steady at 21.70%, while the operating expenses over the recent quarter were at $147.8 million. This represented a -16.86% of the company’s total revenues which amounted $126.47 million. With this in place, we can see that the company’s diluted EPS declined -$1.25 on the year-over-year period, shrinking to -$0.47 as given in the last earnings report.
In terms of the balance sheet & cash flow as of (Jun 2020), the total assets figure advanced to $6.15 billion from $25.98 billion over the previous quarter. Short term investments amounted to $36.07 million while total current assets were at $1.53 billion. The cash flow from operating activities totaled -$80.46 million, significantly lower than the $613.0 million reported in the year-ago quarter. The company’s free cash flow for the quarter was -$121.48 million.
Insiders own 5.60% of the company shares, while shares held by institutions stand at 77.40% with a share float percentage of 160.65M. The top two institutional holders are FMR, LLC with over 13.3 million shares worth more than $532.63 million. As of Jun 29, 2020, FMR, LLC held 13.49% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the investment firm holding over 10.14 million shares as of Jun 29, 2020. The firm’s total holdings are worth over $406.36 million and represent 10.29% of shares outstanding.